Next, we established HepG2 cells xenografted tumor model in nude mice to examine the effect of FD10 on tumor therapy in vivo.
Blocking PLIF by specific antibodies in a tolerant breast cancer model in nude mice resulted in tumor cell apoptosis and rejection.
Finally, we investigated the in-vivo osteogenic activities of the novel TEB in a subcutaneous bone induction model in nude mice.
The results in tumour model in nude mice demonstrate the possibility to deliver paclitaxel by oral route and the prospect of such formulations in increasing response to anticancer drug therapy.
WST-8 based Colorimetric Assay Cell Counting kit 8 (CCK-8) in vitro and xenograft transplantation model in nude mice was used to evaluate cell proliferation and growth respectively.
Finally, the in vivo potency of RM-133 was evaluated on a xenograft model in nude mice with HL-60 tumors, which has resulted in the blocking of tumor progression by 57%.
Such investigations are more easily performed in the laboratory, and to this end, a tumor model in nude mice was established to simulate several aspects of the postmenopausal breast cancer patient.
In a full skin defect model in nude mice, VEGF levels were significantly increased compared to controls in VEGF gene activated scaffolds 14 d after implantation, but not in skin from the wound edge.
With the sufficiently long half-decay time demonstrated by pharmacokinetics studies, the PEGylated Au DENPs enabled not only X-ray CT blood pool imaging of mice and rats after intravenous injection of the particles, but also effective CT imaging of a xenograft tumor model in nude mice.
In this study, we first applied bioluminescence imaging (BLI) and MRI to assess non-invasively intracranial tumor growth in an orthotopic glioma model in nude mice.
Activity of Nutlins-3 against a human osteosarcoma xenograft model in nude mice showed 90% inhibition of tumor growth relative to control [68].
